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ABSTRACT
Bladder pheochromocytomas are extremely rare and con-
stitute less than 5% of bladder tumors. The initial symp-
toms of the patient are mostly nonspecific caused by
hypertension. The postmicturition hypertensive crisis is
the typical warning sign of this disease. In this article, we
present a 29-year-old female having hypertensive attacks
following micturition. Radiological imaging techniques re-
vealed a 3x3x4-cm bladder tumor that was hormonally
active. This is the first case reported of bladder pheochro-
mocytoma that was laparoscopically treated without using
the adjunct transurethral resection. The postoperative fol-
low-up of the patient confirms the success of the surgical
procedure.
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INTRODUCTION
Paragangliomas are extraadrenal neoplasms of neural
crest derivation that are called pheochromocytoma if hor-
monally active. Bladder pheochromocytomas are exceed-
ingly rare, accounting for less than 5% of bladder tumors.1
The most common presenting symptoms of bladder para-
ganglioma are hypertensive attacks precipitated by mic-
turition (65% to 75%) and hematuria (55% to 58%).2 They
are believed to arise from embryonic rests of chromaffin
cells in the sympathetic plexus of the detrusor muscle.3 In
this article, we present the case of a 29-year-old female
patient with a vesical tumor and experiencing hyperten-
sive attacks after micturition.
CASE REPORT
A 29-year-old woman was admitted to our hospital with
complaints of hypertension and palpitation attacks after
micturition occurring for 1 year. Her history revealed that
she suffered from palpitations and headache following
micturition. She had no urinary tract symptoms including
gross hematuria and urgency. Her medical history and
physical examination were completely normal. Blood
pressure measurements during preoperative hospitaliza-
tion showed a systolic range of 110 mm Hg to 200 mm Hg.
Her pulse rate fluctuated between 70 and 106 while she
was supine.
Preoperative imaging techniques showed the existence of
a vesical tumor. On magnetic resonance imaging (MRI) of
the abdomen, a 3x3x4-cm soft tissue mass located antero-
laterally on the right side of the vesical dome was visual-
ized (Figure 1). Also, the same pathological mass was
detected in the bladder on computerized tomography
(CT) of the abdomen. No other metastatic lesion implying
the malignancy of the tumor was found on chest x-ray and
iodine 131-methliodobenzylguanidine (
131I –MIBG) scan.
Laboratory tests including plasma and 24-hour urine col-
lections for catecholamines showed high levels (Table 1).
The mass was functional.
Phenoxybenzamine 30 mg twice daily was continued for
1 month during the preoperative preparation period, and
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CASE REPORTthe arterial blood pressure range was brought down to
normal levels.
In the operating room before starting the surgical proce-
dure, initial cystoscopic examination with the patient un-
der general anesthesia revealed a lobulated submucosal
mass on the right anterolateral side of the bladder dome
(Figure 2). The lesion was away from the ureteral ori-
fices. The laparoscopic procedure was started with gen-
eral exploration of the abdomen through the 10-mm um-
bilical port. Two additional ports, a 10-mm port on the
right site of umbilical port and a 5-mm port on the left
side, were used during the operation (Figure 3). The
vesical mass was protruding into the abdomen under
the peritoneum (Figure 4). The peritoneal covering of the
lesion was opened first, and then the fatty vesicular tissue
around the mass was dissected with careful hemostasis.
The lesion was surrounded by detrusor muscle. During
the manipulation of the mass, significant blood pressure
elevations occurred that required serious antihypertensive
interventions and interrupted the surgical procedure. After
determination of the lateral borders of the mass, the blad-
der was partially resected including a mass with a 1-cm
margin. After the removal of the specimen, the torn blad-
der wall was repaired. The first layer of mucosa was
closed continuously with a 2.0-polyglactin suture applied
with an Endostitch device (Autosuture Corp, Norwalk,
Conn). The second layer of detrusor muscle together with
peritoneum was repaired with 2 interrupted U-shaped
mattress sutures by using the same device. Distension of
the bladder with methylene blue and saline solution did
not show any leakage from the suture sites. A closed
suction drain was left in the pelvis. An 18 F silicone Foley
catheter was placed into the bladder transurethrally. Total
surgical time was 290 minutes. Blood loss was approxi-
mately 200 mL. The patient ate breakfast 12 hours after the
operation. In the postoperative period, no hypertensive
attacks occurred despite the cessation of antihypertensive
drugs. The patient was discharged on the 10th postoper-
ative day after removal of the Foley catheter. Two months
after the surgery, the patient was normotensive and rid of
her past complaints. Her endocrinological tests returned
to normal levels.
The final histopathological examination confirmed the
diagnosis of bladder pheochromocytoma with free surgi-
cal margins.
Table 1.
Results of Plasma and 24-Hour Urine Tests
Results Normal Range
Plasma
Noradrenaline (pg/mL) 1063 95–445
Adrenaline (pg/mL) 60 10–67
24-Hour Urine
Normetanephrine (microgram) 5171 354
Metanephrine (microgram) 126 298
Vanillylmandelic acid (milligram) 10.2 1.5–7
Figure 1. Sagittal MRI view of the vesical tumor.
Figure 2. Cystoscopic view of the lesion.
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Extraadrenal paragangliomas, which account for 5% to
10% of these tumors, are most often found in the retro-
peritoneum, thorax, and urinary bladder. The first case of
extraadrenal paragangliomas in the urinary bladder was
reported in 1953.4 More than 200 cases have been re-
ported in the literature. However, this is the second case
reported in the literature of bladder pheochromocytoma
treated laparoscopically.
Typical symptoms of these tumors are related to increased
catecholamine release in association with detrusion dur-
ing micturition and consist of headache, palpitations,
sweating, blurred vision, and hypertension. Painless he-
maturia is also another common symptom. According to
localization of the tumor in the bladder, obstructive symp-
toms have also been reported.5
Diagnosis of a functionally active pheochromocytoma can
be confirmed in almost all patients with the demonstration
of elevated serum basal catecholamine levels and urinary
total or fractionated catecholamine levels.6 In addition to
this, these tumors also secrete other bioactive amines and
peptides, such as neuropeptide Y, somatostatin, vasoac-
tive intestinal peptide, gastrin, and serotonin.7,8 This may
explain the hypertensive attacks precipitated by micturi-
tion in some cases of bladder paraganglioma in patients
with normal catecholamine levels.2
Computed tomography and magnetic resonance imaging
are used to determine the size, location, and local extent
of the tumor.1 Nuclear medicine scanning using the
radioisotope131iodine metaiodobenzylguanidine is the im-
aging study of choice for localizing small pheochromocy-
tomas and has sensitivity and specificity of 77% to 90%
and 95% to 100%, respectively.9 Recently, positron emis-
sion tomography (PET) imaging has been described as a
highly sensitive adjunctive test for detecting extraadrenal
pheochromocytomas and its existing metastases.10
Biopsy should not be considered as a diagnostic method
due to the risk of a hypertensive crisis as occurs in adrenal
pheochromocytomas. Also any cystoscopic intervention
in the diagnosis of bladder pheochromocytomas requires
blood pressure control with alpha-adrenergic blockade
and use of an operating room. Therefore in our case, we
Figure 3. Port sites during the laparoscopic intervention.
Figure 4. Laparoscopic view of the lesion protruding into the
abdomen.
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room.
Careful preoperative alpha blockade for at least 1 week to
2 weeks is necessary for neutralization of the effects of
released catecholamines.11 After the initiation of alpha
blockade if tachycardia and arrhythmias occur, the use of
beta-blockers may be planned.
Standard treatment of benign-looking bladder pheochro-
mocytomas are localized partial resection of the bladder
by keeping the tumor intact. Because no defined histo-
logical features exist to safely distinguish benign and ma-
lignant pheochromocytomas, if any local invasion or
lymph node metastasis occurs, radical cystectomy with
pelvic lymph node dissection is performed. Even with
local invasion or metastatic spread, excision should be
performed to prolong survival and provide palliation.1
Radiotherapy and chemotherapy have limited effective-
ness in the treatment of locally recurrent or metastatic
pheochromocytoma. In general, radiotherapy is consid-
ered only in the palliative treatment of painful bony me-
tastasis or spinal cord compression.1 Approximately 10%
of bladder pheochromocytomas are malignant. Therefore,
although the initial lesion is solitary and totally resected,
life-long follow-up is necessary to define any metachro-
nous metastases and localized recurrences.3
Kozlowski and collegues11 performed the first laparo-
scopic partial cystectomy to treat vesical pheochromocy-
toma.11 In this procedure, endoscopic manipulation is also
associated with laparoscopy by using cystoscopic resec-
tion. This shows in localized preoperatively benign-look-
ing lesions of bladder pheochromocytomas that laparo-
scopic partial excision of the tumor can be performed. In
our case, we performed laparoscopic partial cystectomy
without applying adjunct transurethral resection. The tu-
mor was totally excised, and the lesion kept intact with a
fine vesical tissue margin. The specimen was also ex-
tracted with a nylon bag.
CONCLUSION
Correct diagnosis and tumor location together with suffi-
cient preoperative preparation of the patient with bladder
pheochromocytoma are enough for successful laparo-
scopic resection by surgical teams experienced in mini-
mally invasive surgery.
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